HESIRE CONSULTORIA EN FARMACOLOGIA SL
Company details
- Active NIF/CIF: B86819521
-
-
-
-
Address: Av. Víctimas del Terrorismo, 37, 28806 Alcalá de Henares, Madrid, España See in map
-
-
Featured products:
More information on HESIRE CONSULTORIA EN FARMACOLOGIA SL
-
30/11/2018 | BORME act no.: 481250 | Register: MADRIDCambio de domicilio social
-
04/02/2016 | BORME act no.: 50079 | Register: MADRIDPérdida del caracter de unipersonalidad
-
03/10/2013 | BORME act no.: 424051 | Register: MADRIDConstitución
-
03/10/2013 | BORME act no.: 424051 | Register: MADRIDDeclaración de unipersonalidad
-
03/10/2013 | BORME act no.: 424051 | Register: MADRIDNombramientos
Other information
The CIF assigned to HESIRE CONSULTORIA EN FARMACOLOGIA SL is B86819521, and its commercial status is active. The company carries out its operations within the CNAE 4673 - Comercio al por mayor de madera, materiales de construcción y aparatos sanitarios. Likewise, its SIC code 5039 - Materiales para la construcción identifies it.
HESIRE CONSULTORIA EN FARMACOLOGIA SL employs a team of Between 1 and 9 employees and records an annual turnover of less than 2 million euros. The entity is registered in the Mercantile Registry of Madrid and has 2 registration charges. The last announcement in Borme was published on 30/11/2018, while the most recent deposit of ordinary annual accounts is from the year 2023.
To access the contact information of HESIRE CONSULTORIA EN FARMACOLOGIA SL, such as the phone number, address, or website, visit the Company Data module.
If you require additional information about HESIRE CONSULTORIA EN FARMACOLOGIA SL, you can review one of our available financial reports, the Annual Accounts of the company, or verify its default incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about HESIRE CONSULTORIA EN FARMACOLOGIA SL comes from official sources and is regularly updated.
Do you want to know more about HESIRE CONSULTORIA EN FARMACOLOGIA SL??
Find out more about this company by consulting these reports: